Coherence Neuro tests brain implant on 3 patients to treat aggressive glioblastoma, company confirms

Image for Coherence Neuro tests brain implant on 3 patients to treat aggressive glioblastoma, company confirms

Imagine a brain implant that doesn't just read your thoughts…

but hunts your cancer.

That's not sci-fi anymore.

It just happened in three real human patients.


🧠 Meet SOMA — the chip that thinks of cancer as a signal

A San Francisco startup called Coherence Neuro just pulled off something the neurotech world has been whispering about for years.

They slipped a button-sized implant into three patients' brains during tumour surgery.

Let it run for 30 minutes.

Listened in. Zapped back. Then pulled it out.

And the data they got might rewrite how we treat one of the deadliest cancers on Earth.


⚡ The wild science behind it

Here's the part that breaks your brain a little.

Cancer isn't just biology.

It's electrical.

Aggressive brain tumours literally hijack the brain's own bioelectric signals to grow faster.

SOMA is built to interrupt that hijack — in real time.

  • 🔬 Reads the tumour's unique electrical fingerprint
  • ⚡ Fires back targeted stimulation to slow its growth
  • 📲 Pairs with a coin-sized wearable behind the ear
  • 📱 Streams live data to a doctor's phone app

No more brutal hospital marathons.

Just cancer… being monitored 24/7. Like a heart rate.


💀 Why glioblastoma is the right enemy to pick

Glioblastoma is the cancer that took Ted Kennedy. John McCain. Beau Biden.

The numbers are merciless:

  • 📉 Median survival: 12–18 months
  • 🩻 5-year survival rate: around 5–7%
  • 🧬 Almost zero meaningful treatment progress in decades

This is the wall oncology keeps slamming into.

And Coherence just walked up to it with a soldering iron.


🚀 The Elon Musk shadow in the room

You can't tell this story without saying the quiet part loud.

Neuralink's head neurosurgeon is an active adviser and investor.

Key investigators from Musk's trials are running Coherence's next studies.

The company raised a $10M seed last November and is moving fast.

Founded in 2022 by two engineering PhDs — Ben Woodington and Elise Jenkins — Coherence is basically Neuralink's cousin pointing the same technology at a totally different war.

Not movement. Not memory. Mortality itself.


🌊 The bigger idea hiding inside this story

For a century, we've treated cancer like an invader to be poisoned, burned, or cut out.

Chemo. Radiation. Surgery. Repeat.

SOMA hints at a different future entirely.

Cancer as a chronic, manageable signal — something you live alongside, not something you race against.

And if the same biophysics work elsewhere in the body — lungs, breast, pancreas — this stops being a brain story.

It becomes the story.

Three patients. Thirty minutes. One very loud signal that the next era of medicine has officially begun.

That's all for now!